Analysis of stepwise genetic changes in an AIDS-related Burkitt's lymphoma

International Journal of Cancer

Volumn 88, Issue 5, 2000, Pages 744-750

  Fais, Franco ^a,b   Fronza, Gilberto ^a   Roncella, Silvio ^c   Inga, Alberto ^a   Campomenosi, Paola ^a   Cutrona, Giovanna ^a,b   Pezzolo, Annalisa ^d   Fedeli, Franco ^c   Abbondandolo, Angelo ^a   Chiorazzi, Nicholas ^e   Pistoia, Vito ^d   Ferrarini, Manlio ^a,b  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

^d G GASLINI INSTITUTE   (Italy)

^e NORTH SHORE UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN KAPPA CHAIN; PROTEIN P53;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ALLELE; ARTICLE; B LYMPHOCYTE; BURKITT LYMPHOMA; CONTROLLED STUDY; EPSTEIN BARR VIRUS; GENE REARRANGEMENT; GERMINAL CENTER; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOGLOBULIN GENE; IMMUNOGLOBULIN VARIABLE REGION; ONCOGENE C MYC; POINT MUTATION; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

ACQUIRED IMMUNODEFICIENCY SYNDROME; BASE SEQUENCE; BURKITT LYMPHOMA; DNA, NEOPLASM; GENE REARRANGEMENT, B-LYMPHOCYTE; GERMINAL CENTER; HUMANS; IMMUNOGLOBULIN VARIABLE REGION; MOLECULAR SEQUENCE DATA; PROTO-ONCOGENE PROTEINS C-MYC; SEQUENCE HOMOLOGY, NUCLEIC ACID; TRANSLOCATION, GENETIC; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0034569327     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0215(20001201)88:5<744::AID-IJC10>3.0.CO;2-E     Document Type: Article

References (41)

1. c-Myc hot spot mutations in lymphomas result in inefficient ubiquitinafion and decreased proteasome-mediated turnover
2. Human antilipid A monoclonal antibodies bind to human B cells and the i antigen on cord red blood cells
3. Mutations in the coding region of c-myc occur frequently in acquired immunodeficiency syndrome-associated lymphomas
4. Point mutations of the BCL-6 gene in Burkitt's lymphoma
5. The CDRI sequences of a major proportion of human germline Ig V(H) genes are inherently susceptible to amino acid replacement
6. Transcriptional activation of an unre-arranged and untranslocated c-myc oncogene by translocation of a C lambda locus in Burkitt
7. Transfection of the c-myc oncogene into normal Epstein-Barr virus-harboring B cells results in new phenotypic and functional features resembling those of Burkitt lymphoma cells and normal centroblasts
8. Human c-myc onc gene is located on the region of chromosome 8 that is translocated in Burkitt lymphoma cells
9. Variable morphology of human immunodeficiency virus-associated lymphomas with c-myc re-arrangements
10. Analysis of heavy and light chain pairings indicates that receptor editing shapes the human antibody repertoire
11. Immunoglobulin V region gene use and structure suggest antigen selection in AIDS-related primary effusion lymphomas
12. A simple p53 functional assay for screening cell lines, blood, and tumors
13. p53 mutations in human lymphoid malignancies: Association with Burkitt lymphoma and chronic lymphocytic leukemia
14. Molecular pathogenesis of AIDS-related lymphomas
15. Re-expression of RAG-1 and RAG-2 genes and evidence for secondary re-arrangements in human germinal center B lymphocytes
16. An anti-B cell autoantibody from Wiskott-Aldrich syndrome which recognizes i blood group specificity on normal human B cells
17. Intraclonal molecular heterogeneity suggests a hierarchy of pathogenetic events in Burkitt's lymphoma
18. Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death
19. Proteins of the Myc network: Essential regulators of cell growth and differentiation
20. A link between increased transforming activity of lymphoma-derived MYC mutant alleles, their defective regulation by p107, and altered phosphorylation of the c-Myc transactivation domain
21. Simple identification of dominant p53 mutants by a yeast functional assay
22. Screening patients for heterozygous p53 mutations using a functional assay in yeast
23. Cellular origin of human b-cell lymphomas
24. The I binding specificity of human V(H) 4-34 (V(H) 4-21) encoded antibodies is determined by both V(H) framework region 1 and complementarity determining region 3
25. Molecular controls of growth arrest and apoptosis: p53-Dependent and independent pathways
26. The J kappa proximal region of the human K locus contains three uncommon V kappa genes which are arranged in opposite transcriptional polarities
27. The pathogenesis of Burkitt's lymphoma
28. Antigen receptor engagement turns off the V(D)J recombination machinery in human tonsil B cells
29. RAG2: GFP knockin mice reveal novel aspects of RAG2 expression in primary and peripheral lymphoid tissues
30. c-myc activation renders proliferation of Epstein-Barr virus (EBV)-transformed cells independent of EBV nuclear antigen 2 and latent membrane protein 1
31. The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular proliferation
32. Burnet's unhappy hybrid
33. Two acquired immunodeficiency syndrome-associated Burkitt's lymphomas
34. Cytogenetic rearrangement of C-MYC oncogene occurs prior to infection with Epstein-Barr virus in the monoclonal malignant B cells from an AIDS patient
35. Restricted expression of EBV latent genes and T-lymphocyte-detected membrane antigen in Burkitt's lymphoma cells
36. Preferential clustering of chromosomal breakpoints in Burkitt's lymphomas and L3 type acute lymphoblastic leukemias with a t(8;14) translocation
37. Epstein-Barr virus nuclear antigen 2 specifically induces expression of the B-cell activation antigen CD23
38. Epstein-Barr virus latent membrane protein (LMP1) and nuclear proteins 2 and 3C are effectors of phenotypic changes in B lymphocytes: EBNA-2 and LMP1 cooperatively induce CD23
39. Expression of Epstein-Barr virus nuclear antigen-1 induces B cell neoplasia in transgenic mice
40. Somatic mutations in c-myc intron I cluster in discrete domains that define protein binding sequences
41. Continued RAG expression in late stages of B cell development and no apparent reinduction after immunization